Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.460
-0.060 (-2.38%)
At close: Apr 28, 2026, 4:00 PM EDT
2.460
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:00 PM EDT
Acumen Pharmaceuticals Employees
Acumen Pharmaceuticals had 61 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
61
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,989,098
Market Cap
177.64M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| Protalix BioTherapeutics | 226 |
| Tonix Pharmaceuticals Holding | 142 |
| Cartesian Therapeutics | 75 |
| Precision BioSciences | 68 |
| Korro Bio | 58 |
| Corbus Pharmaceuticals Holdings | 36 |
| Whitehawk Therapeutics | 23 |
ABOS News
- 4 weeks ago - Acumen Pharmaceuticals Earnings Call Transcript: Q4 2025 - Transcripts
- 4 weeks ago - Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2025 and Business Highlights - GlobeNewsWire
- 5 weeks ago - Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2025 Financial Results on March 26, 2026 - GlobeNewsWire
- 5 weeks ago - Acumen Pharmaceuticals Transcript: Stifel 2026 Virtual CNS Forum - Transcripts
- 6 weeks ago - Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio - GlobeNewsWire
- 7 weeks ago - Acumen Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum - GlobeNewsWire
- 5 months ago - Acumen Pharmaceuticals Earnings Call Transcript: Q3 2025 - Transcripts
- 5 months ago - Acumen Pharmaceuticals Transcript: Stifel 2025 Healthcare Conference - Transcripts